Plandaí Biotechnology, Inc. - PLPL

Plandaí Biotechnology, Inc. – PLPL

       Business Description

Plandaí Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market.
In November 2011, Plandaí Biotechnology, Inc. through its wholly-owned subsidiary acquired 100% ownership of Global Energy Solutions Corporation Limited (GES), through a share exchange.
Since 2002, GES successfully conducted documented research producing extracts from a variety of live plant materials.

Plandai Unique Selling Point (USP)
The FDA defines bioavailability as “the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action”.
In the market today, green tea extracts, with an average selling price of $500/kg, have poor bioavailability of between 1-10%.
Plandaí proprietary plant extracts have shown in published USDA studies to have improved bioavailability of between 60-80%, far exceeding anything currently available today.
Our extracts include but are not limited to, gallate catechins from green tea, (catechin gallate (CG),epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG); carotenoids (lycopene)from tomatoes, as well as citrus bioflavonoids and limonoids.
Furthermore, Plandaí’s gallate catechin extract will be the active ingredient in formulated products supporting weight loss, antiaging, the lowering of blood cholesterol, the regulation of high blood pressure and controlling diabetes 1 and 2.
This means, that Plandaí’s extracts deliver a more meaningful and beneficial dose at highly competitive prices to the consumer, in wellness terms.
A conservative, quick “back of the envelope calculation” gives Plandaí an income of $27,000,000 in 2012-2013, accelerating within 5 years of inception to $90,000,000+.
Once we’ve pounded the streets and the dust has settled, Plandaí’s market valuation will be one that truly reflects its ability to deliver products that far exceed ANYTHING that is available, making us, to date, the most undervalued company in our space.
Source of Raw Material Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing the extracts in-house. Thus Plandaí is able to guarantee continuity of supply, as well as quality throughout the whole process.

Products and Services
Our extracts include but are not limited to, gallate catechins from green tea, (catechin gallate
(CG),epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG),
carotenoids (lycopene)from tomatoes, as well as citrus bioflavonoids and limonoids.

Business Partners
In November 2011, Plandaí Biotechnology, Inc. through its wholly-owned subsidiary acquired 100% ownership of Global Energy Solutions Corporation Limited (GES), through a share exchange.


Recent News

Thursday, January 12, 2012

DIAMOND RANCH FOODS, LTD., NEW FinancialsEDGAR Online Financials (Thu, Jan 12)

Wednesday, November 23, 2011

DIAMOND RANCH FOODS, LTD., NEW Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered SEDGAR Online (Wed, Nov 23)

Management Team
Roger Duffield
President, Chief Executive officer and member of the Board of Directors
Callum Baylis-Duffield
Vice-President and Global Director: Marketing
Sales
David Rzepnicki
Chief Financial Officer and member of the Board of Directors
Tim Matula
Investor Relations and member of the Board of Directors
Contact Us
Corporate Headquarters
Address: 2226 Eastlake Ave E, #156
Seattle, Washington, 98102, USA
Phone: (425) 466-0212
Website: www.plandaibiotech.com (Under Construction)
Email: Info@plandaibiotech.com

9WV5UBKN4TH7 Follow Us on Facebook http://www.sizzlingstockpicks.com/ http://www.stockgoodies.com/